Lab-made antibodies offer potential post-exposure measles therapy
Scientists isolated four potent monoclonal antibodies from a vaccinated donor’s blood that block measles by targeting the virus’s H and F proteins. In rodent tests, these antibodies reduced lung virus after exposure, suggesting potential post-exposure or preventive use, though they are not a substitute for vaccination and delivery challenges remain. Further testing is needed before any human therapy.